264 Correlation of virus-specific CD8+ T cells to clinical response following treatment with Pexa-Vec and Cemiplimab in patients with advanced renal cell carcinoma

• Gavin Thurston,
• Israel Lowy,
• Vladimir Jankovic,
• Myles Dillon,
• Lianjie Li,
• Jeongsook Bang,
• Nicholas Gaspar,
• Jessica Kuhnert,
• Nathalie Fiaschi,
• Glenn Kroog,
• Kyoung Soo Ha,
• Raquel Deering

Affiliations

Gavin Thurston

Aff28 grid.418961.30000000404722713Regeneron Tarrytown NY USA

Israel Lowy

Aff4 grid.419971.3Medarex, Bloomsbury, NJ/Bristol-Myers Squibb Company Wallingford CT USA

Vladimir Jankovic

Aff3 Celgene Cellular Therapeutics Warren NJ USA

Myles Dillon

1Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA

Lianjie Li

1Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA

Jeongsook Bang

2Sillajen Inc., Seoul, Korea, Republic of

Nicholas Gaspar

3Sillajen Biotherapeutics, San Francisco, CA, USA

Jessica Kuhnert

1Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA

Nathalie Fiaschi

1Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA

Glenn Kroog

1Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA

Kyoung Soo Ha

3Sillajen Biotherapeutics, San Francisco, CA, USA

Raquel Deering

1Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA